Brain response to putative pheromones in homosexual men.
Journal: 2005/July - Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
Abstract:
The testosterone derivative 4,16-androstadien-3-one (AND) and the estrogen-like steroid estra-1,3,5(10),16-tetraen-3-ol (EST) are candidate compounds for human pheromones. AND is detected primarily in male sweat, whereas EST has been found in female urine. In a previous positron emission tomography study, we found that smelling AND and EST activated regions covering sexually dimorphic nuclei of the anterior hypothalamus, and that this activation was differentiated with respect to sex and compound. In the present study, the pattern of activation induced by AND and EST was compared among homosexual men, heterosexual men, and heterosexual women. In contrast to heterosexual men, and in congruence with heterosexual women, homosexual men displayed hypothalamic activation in response to AND. Maximal activation was observed in the medial preoptic area/anterior hypothalamus, which, according to animal studies, is highly involved in sexual behavior. As opposed to putative pheromones, common odors were processed similarly in all three groups of subjects and engaged only the olfactory brain (amygdala, piriform, orbitofrontal, and insular cortex). These findings show that our brain reacts differently to the two putative pheromones compared with common odors, and suggest a link between sexual orientation and hypothalamic neuronal processes.
Relations:
Content
Citations
(50)
References
(34)
Chemicals
(2)
Organisms
(1)
Processes
(2)
Anatomy
(1)
Affiliates
(2)
Similar articles
Articles by the same authors
Discussion board
Proc Natl Acad Sci U S A 102(20): 7356-7361

Brain response to putative pheromones in homosexual men

Departments of Clinical Neuroscience and Medicine, Karolinska University Hospital, 171 76 Stockholm, Sweden; and Department of Neuroscience, Center for Gender-Related Medicine, Karolinska Institute, 171 77 Stockholm, Sweden
To whom correspondence should be addressed at: Department of Neuroscience, Karolinska Institute, Retzius väg 8, 171 77 Stockholm, Sweden. E-mail: es.ik.oruen@dnulgreb-civas.aknavi.
Edited by Jan-Åke Gustafsson, Karolinska Institute, Huddinge, Sweden, and approved April 4, 2005
Edited by Jan-Åke Gustafsson, Karolinska Institute, Huddinge, Sweden, and approved April 4, 2005
Received 2004 Oct 27

Abstract

The testosterone derivative 4,16-androstadien-3-one (AND) and the estrogen-like steroid estra-1,3,5(10),16-tetraen-3-ol (EST) are candidate compounds for human pheromones. AND is detected primarily in male sweat, whereas EST has been found in female urine. In a previous positron emission tomography study, we found that smelling AND and EST activated regions covering sexually dimorphic nuclei of the anterior hypothalamus, and that this activation was differentiated with respect to sex and compound. In the present study, the pattern of activation induced by AND and EST was compared among homosexual men, heterosexual men, and heterosexual women. In contrast to heterosexual men, and in congruence with heterosexual women, homosexual men displayed hypothalamic activation in response to AND. Maximal activation was observed in the medial preoptic area/anterior hypothalamus, which, according to animal studies, is highly involved in sexual behavior. As opposed to putative pheromones, common odors were processed similarly in all three groups of subjects and engaged only the olfactory brain (amygdala, piriform, orbitofrontal, and insular cortex). These findings show that our brain reacts differently to the two putative pheromones compared with common odors, and suggest a link between sexual orientation and hypothalamic neuronal processes.

Keywords: olfaction, positron emission tomography, hypothalamus, homosexual males
Abstract

According to animal studies, the choice of sexual partner is highly influenced by sex-specific pheromone signals, which are processed by male and female mating centers located in the anterior hypothalamus (1-3). A lesion of the respective mating center, as well as impairment of pheromone transduction, may alter the coital approach in a sex-specific way (3, 4).

In a majority of animals, pheromone signals are transferred to the hypothalamus from the vomeronasal organ via the accessory olfactory nerve (5). Because our vomeronasal pit lacks neuronal connections to the brain (5, 6), the occurrence of pheromone transduction has long been questioned in humans. Several recent observations, however, suggest that this type of chemical communication cannot be ruled out. Sex steroid-derived compounds such as 4,16-androstadien-3-one (AND) and, less consistently, estra-1,3,5(10),16-tetraen-3-ol (EST) have been reported to induce sex-specific effects on the autonomic nervous system, mood, and context-dependent sexual arousal (7-12). The exact effects of AND and EST vary with the administered dose and experimental design, but, nevertheless, they seem to be sex-differentiated (especially with respect to AND), and thus to differ from the effects of ordinary odors. Studies with positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) have shown that smelling both AND and of EST activates the human brain (13-15), even in nonodorous concentrations (14, 15). AND is a derivative of testosterone and is primarily produced in male sweat (16), whereas EST is an estrogen-resembling steroid that has been detected in the urine of pregnant women (17). Male sweat has recently been reported to alter the pulsative hypothalamic release of luteinic hormone in females in an ovulation-promoting way (18). Thus, although it is premature to classify AND and EST as pheromones, the data suggest that they may function as chemosignals.

In a previous PET study of regional cerebral blood flow (rCBF) in heterosexual subjects (13), we found that smelling AND and EST caused a sex-differentiated activation of the anterior hypothalamus. In women, AND activated the preoptic area and ventromedial nuclei, whereas, in men, activation by EST involved an area covering the paraventricular and dorsomedial nuclei. In contrast, when men smelled AND and women EST, activations were found only in amygdala plus piriform cortex, anterior insular cortex, orbitofrontal cortex, and anterior cingulate cortex. These areas are reported to process the signals of common odors (19, 20, 21), and were possibly recruited by the odor components of AND and EST. Our interpretation of this sex-differentiated pattern of activation was that the two steroid compounds may act bimodally, both as pheromones and odors. We proposed the hypothesis that the anterior hypothalamus primarily processed signals from the pheromone-like component of AND and EST, whereas the olfactory brain primarily mediated the signals of their odor component. Depending on the sex of the responder in relation to the specific compound (AND or EST), one pathway dominated, whereas the other was suppressed. This hypothesis was based upon observations of a similar phenomenon in studies of other bimodal odorants (for example, acetone) (22).

In the present study, we investigated the question whether the pattern of activation induced by AND and EST could be related to sexual orientation rather than to the biological sex. We therefore compared the pattern of activation between homosexual men and heterosexual men and women. The activations were induced by smelling AND, EST, and ordinary odors (here denoted as OO). Smelling of odorless air served as the baseline condition. The following issues were addressed in particular: (i) In homosexual men (HoM), is the hypothalamus activated by AND, EST, or both? (ii) Is the pattern of activation in HoM similar to that in heterosexual men (HeM) and that in heterosexual women (HeW), or are entirely different regions involved in HoM? (iii) If there are group differences, are they confined to the pheromone-like compounds, or do they occur also with OO?

Activations calculated with one-random effect analysis (spm99). All the significant clusters, calculated with T-threshold at P = 0.001 (a corrected P<0.05), are included. Talairach coordinates indicate local maxima. The OO clusters also covered minor portions of anterior cingulate. R, right; L, left.

Activations calculated with conjunctional analysis (SPM99). T-threshold at P = 0.001 (corrected P < 0.05). R, right; L, left.

DHEAS, dehydroepiandrosterone sulfate; FSH, follicle-stimulating hormone; LH, luteinizing hormone.

Acknowledgments

We thank Professor Per Roland for advice in writing the manuscript, Julio Gabriel and Martti Lampinen for technical assistance, and Professor Sigbritt Werner for suggestions about the choice of hormone analyses. We thank the Swedish Medical Research Council, Karolinska Institute, and the Magnus Bergvall Foundation for financial support.

Acknowledgments

Notes

Author contributions: I.S. designed research; I.S., H.B., and P.L. performed research; I.S. analyzed data; P.L. recruited subjects; and I.S. wrote the paper.

This paper was submitted directly (Track II) to the PNAS office.

Abbreviations: HoM, homosexual men; HeM, heterosexual men; HeW, heterosexual women; AND, 4,16-androstadien-3-one; EST, estra-1,3,5(10),16-tetraen-3-ol; AIR, odorless air; OO, ordinary odors; PET, positron emission tomography; rCBF, regional cerebral blood flow; MRI, magnetic resonance imaging; ROI, region of interest.

Notes
Author contributions: I.S. designed research; I.S., H.B., and P.L. performed research; I.S. analyzed data; P.L. recruited subjects; and I.S. wrote the paper.
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: HoM, homosexual men; HeM, heterosexual men; HeW, heterosexual women; AND, 4,16-androstadien-3-one; EST, estra-1,3,5(10),16-tetraen-3-ol; AIR, odorless air; OO, ordinary odors; PET, positron emission tomography; rCBF, regional cerebral blood flow; MRI, magnetic resonance imaging; ROI, region of interest.

References

  • 1. Paredes, R. G., Tzschentke, T. &amp; Nakach, N. (1998) Brain Res.813, 1-8. [[PubMed]
  • 2. Dorner, G., Docke, F. &amp; Moustafa, S. (1968) J. Reprod. Fertil.17, 583-586. [[PubMed]
  • 3. Paredes, R. G. &amp; Baum, M. J. (1995) J. Neurosci.15, 6619-6630.
  • 4. Stowers, L., Holy, T. E., Meister, M., Dulac, C. &amp; Koentges, G. (2002) Science295, 1493-1500. [[PubMed]
  • 5. Keverne, E. B. (2002) Curr. Biol.12, R807-R809. [[PubMed]
  • 6. Trotier, D., Eloit, C., Wassef, M., Talmain, G., Bensimon, J. L., Doving, K. B. &amp; Ferrand, J. (2000) Chem. Senses4, 369-380. [[PubMed]
  • 7. Grosser, B. I., Monti-Bloch, L., Jennings-White, C. &amp; Berliner, D. L. (2000) Psychoneuroendocrinology25, 289-299. [[PubMed]
  • 8. Jacob, S., Garcia, S., Hayreh, D. &amp; McClintock, M. K. (2002) Horm. Behav.42, 274-283. [[PubMed]
  • 9. Jacob, S., Hayreh, D. J. &amp; McClintock, M. K. (2001) Physiol. Behav.74, 15-27. [[PubMed]
  • 10. Bensafi, M., Brown, W. M., Tsutsui, T., Mainland, J. D., Johnson, B. N., Bremner, E. A., Young, N., Mauss, I., Ray, B., Gross, J., et al. (2003) Behav. Neurosci.117, 1125-1134. [[PubMed]
  • 11. Bensafi, M., Brown, W. M., Khan, R., Levenson, B. &amp; Sobel, N. (2004) Psychoneuroendocrinology29, 1290-1299. [[PubMed]
  • 12. Bensafi, M., Brown, W. M., Khan, R., Levenson, B. &amp; Sobel, N. (2004) Behav. Brain Res.152, 11-22. [[PubMed]
  • 13. Savic, I., Berglund, H., Gulyas, B. &amp; Roland, P. (2001) Neuron31, 661-668. [[PubMed]
  • 14. Sobel, N., Prabhakaran, V., Hartley, C. A., Desmond, J. E., Glover, G. H., Sullivan, E. V. &amp; Gabrieli, J. D. (1999) Brain122, 209-217. [[PubMed]
  • 15. Jacob, S., Kinnunen, L. H., Metz, J., Cooper, M. &amp; McClintock, M. K. (2001) NeuroReport12, 2391-2394. [[PubMed]
  • 16. Gower, D. B. &amp; Ruparelia, B. A. (1983) J. Endocrinol.137, 167-187. [[PubMed]
  • 17. Thysen, B., Eliott, W. H. &amp; Katzman, P. A. (1968) Steroids11, 73-87. [[PubMed]
  • 18. Preti, G., Wysocki, C. J., Barnhart, K. T., Sondheimer, S. J. &amp; Leyden, J. (2003) J. Biol. Reprod.68, 2107-2113. [[PubMed]
  • 19. Bengtsson, S., Berglund, H., Gulyas, B., Cohen, E. &amp; Savic, I. (2001) NeuroReport12, 2027-2033. [[PubMed]
  • 20. Zatorre, R. J., Jones-Gotman, M., Evans, A. C. &amp; Meyer, E. (1992) Nature360, 339-341. [[PubMed]
  • 21. Savic, I., Gulyas, B., M. Larsson, M. &amp; Roland, P. (2000) Neuron26, 735-745. [[PubMed]
  • 22. Savic I., Gulyas, B. &amp; Berglund, H. (2002) Hum. Brain Mapping17, 17-27. [[PubMed]
  • 23. Kinsey, C., Pomeroy, W. B., Martin, C. E. &amp; Gebhard, P. H. (1953) Sexual Behaviour in the Human Female (Saunders, Philadelphia).
  • 24. Gower, D. B., Nixon, A. &amp; Mallet, A. I. (1988) in Perfumery: The Psychology and Biology of Fragrance, eds. Van Toller, S. &amp; Dodd, G. H. (Chapman &amp; Hall, London), pp. 45-47.
  • 25. Friston, K. J., Holmes, A. P. &amp; Worsley, K. J. (1999) NeuroImage10, 1-5. [[PubMed]
  • 26. Frackowiak, R. S. J., Friston, K., Frith, C. D., Dolan, R. J., Price, C. J., Zeki, S., Ashburner, J. &amp; Penny, W. (2003) Human Brain Function (Academic, New York), pp. 725-843.
  • 27. Talairach, J. &amp; Tournoux, P. (1988) Co-planar Stereotaxic Atlas of the Human Brain (Thieme, New York).
  • 28. Schaltenbrand G(1959) Eintuhnung in die Stereotaktischen 0perationen mit Einem Atlas des Menschlichen Gehirns (Thiem, Stuttgart).[Google Scholar]
  • 29. Dudás, B. &amp; Merchenthaler, I. J. (2002) Clin. Endocrinol. Metab.87, 2946-2953. [[PubMed]
  • 30. Schwanzel-Fukuda, M., Bick, D. &amp; Pfaff, D. W. (1989) Brain Res. Mol. Brain Res.6, 311-326. [[PubMed]
  • 31. Dorner, G., Rohde, W., Stahl, F., Krell, L. &amp; Masius, W. G. (1975) Arch. Sex. Behav.4, 1-8. [[PubMed]
  • 32. Swaab, D. F. &amp; Fliers, E. (1985) Science228, 1112-1115. [[PubMed]
  • 33. Allen, L. S., Hines, M., Shryne, J. E. &amp; Gorski, R. A. (1989) J. Neurosci.9, 497-506.
  • 34. Le Vay, S(1991) Science253, 1034-1037. [[PubMed][Google Scholar]
  • 35. Mainland, J. D., Bremner, E. A., Young, N., Johnson, B. N., Khan, R. M., Bensafi, M. &amp; Sobel, N. (2002) Nature419, 802. [[PubMed]
  • 36. Leinders-Zufall, T., Lane, A. P., Puche, A. C., Ma, W., Novotny, M. V., Shipley, M. T. &amp; Zufall, F. (2000) Nature405, 792-796. [[PubMed]
  • 37. Stefanczyk-Krzymowska, S., Krzymowski, T., Grzegorzewski, W., Wasowska, B. &amp; Skipor, J. (2000) Exp. Physiol.85, 801-809. [[PubMed]
  • 38. Rodriguez, I., Geer, C. A., Mok, M. A. &amp; Mombarerts, P. (2000) Nat. Genet.26, 18-19. [[PubMed]
  • 39. Savic I(2002) Curr. Opin. Neurobiol.12, 455-461. [[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.